OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce that it has acquired ApiFix Ltd. (“ApiFix”), including its minimally invasive deformity correction (“MID-C”) system for non-fusion treatment of progressive adolescent idiopathic scoliosis (“AIS”), for 934,768 shares of OrthoPediatrics common stock and $2 million in cash paid at closing, plus milestone payments and an earnout over a period of four years. ApiFix Ltd. is an Israel and Boston, MA based medical device company with a less invasive spinal deformity correction system for non-fusion treatment of progressive AIS. Together with vertebral body tethering, it is one of only two non-fusion technologies approved by the U.S. Food and Drug Administration under its Humanitarian Device Exemption provision.
Read the full article: OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. //
Source: https://www.globenewswire.com/news-release/2020/04/01/2010276/0/en/OrthoPediatrics-Corp-Announces-Acquisition-of-ApiFix-Ltd-with-FDA-Approved-Non-Fusion-Scoliosis-Technology.html